Indian Vaccine Market Report by Monovalent and Combined Vaccines (BCG, HIB, Influenza, Varicella, Typhoid, Japanese Encephalitis, Measles, Tetanus Toxoid, Hepatitis A, Rubella, Diphtheria, Tetanus, and Pertussis (DPT), Oral Polio Vaccine (OPV), MMR, Rotavirus, Hepatitis B, Pneumococcal, Meningococcal, Rabies, HPV, Hexavalent, Dengue Vaccines) 2024-2032

Indian Vaccine Market Report by Monovalent and Combined Vaccines (BCG, HIB, Influenza, Varicella, Typhoid, Japanese Encephalitis, Measles, Tetanus Toxoid, Hepatitis A, Rubella, Diphtheria, Tetanus, and Pertussis (DPT), Oral Polio Vaccine (OPV), MMR, Rotavirus, Hepatitis B, Pneumococcal, Meningococcal, Rabies, HPV, Hexavalent, Dengue Vaccines) 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A554
Buy Now

1   Preface
2   Scope and Methodology

    2.1 Objectives of the Study
    2.2 Stakeholders
    2.3 Data Sources
        2.3.1 Primary Sources
        2.3.2 Secondary Sources
    2.4 Market Estimation
        2.4.1 Bottom-Up Approach
        2.4.2 Top-Down Approach
    2.5 Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1 Overview
    4.2 Key Industry Trends
5   Indian Vaccine Industry
    5.1 Market Overview
    5.2 Market Performance
        5.2.1 Volume Trends
        5.2.2 Value Trends
    5.3 Impact of COVID-19
    5.4 Market Breakup by Segment
    5.5 Market Forecast
        5.5.1 Volume Trends
        5.5.2 Value Trends
6   Market Analysis of Various Monovalent and Combined Vaccines
    6.1 BCG Vaccine Market
        6.1.1 Vaccine Overview
        6.1.2 Market Performance
        6.1.3 Market Breakup by Prescriber
        6.1.4 Market Breakup by Public and Private Sector
        6.1.5 Market Forecast
    6.2 HIB Vaccine Market
        6.2.1 Vaccine Overview
        6.2.2 Market Performance
        6.2.3 Market Breakup by Prescriber
        6.2.4 Market Breakup by Public and Private Sector
        6.2.5 Market Forecast
    6.3 Influenza Vaccine Market
        6.3.1 Vaccine Overview
        6.3.2 Market Performance
        6.3.3 Market Breakup by Prescriber
        6.3.4 Market Breakup by Public and Private Sector
        6.3.5 Market Forecast
    6.4 Varicella Vaccine Market
        6.4.1 Vaccine Overview
        6.4.2 Market Performance
        6.4.3 Market Breakup by Prescriber
        6.4.4 Market Breakup by Public and Private Sector
        6.4.5 Market Forecast
    6.5 Typhoid Vaccine Market
        6.5.1 Vaccine Overview
        6.5.2 Market Performance
        6.5.3 Market Breakup by Prescriber
        6.5.4 Market Breakup by Public and Private Sector
        6.5.5 Market Forecast
    6.6 Japanese Encephalitis Vaccine Market
        6.6.1 Vaccine Overview
        6.6.2 Market Performance
        6.6.3 Market Breakup by Prescriber
        6.6.4 Market Breakup by Public and Private Sector
        6.6.5 Market Forecast
    6.7 Measles Vaccine Market
        6.7.1 Vaccine Overview
        6.7.2 Market Performance
        6.7.3 Market Breakup by Prescriber
        6.7.4 Market Breakup by Public and Private Sector
        6.7.5 Market Forecast
    6.8 Tetanus Toxoid Vaccine Market
        6.8.1 Vaccine Overview
        6.8.2 Market Performance
        6.8.3 Market Breakup by Prescriber
        6.8.4 Market Breakup by Public and Private Sector
        6.8.5 Market Forecast
    6.9 Hepatitis A Vaccine Market
        6.9.1 Vaccine Overview
        6.9.2 Market Performance
        6.9.3 Market Breakup by Prescriber
        6.9.4 Market Breakup by Public and Private Sector
        6.9.5 Market Forecast
    6.10 Rubella Vaccine Market
        6.10.1 Vaccine Overview
        6.10.2 Market Performance
        6.10.3 Market Breakup by Prescriber
        6.10.4 Market Breakup by Public and Private Sector
        6.10.5 Market Forecast
    6.11 DPT (Diphtheria, Tetanus and Pertussis) Vaccine Market
        6.11.1 Vaccine Overview
        6.11.2 Market Performance
        6.11.3 Market Breakup by Prescriber
        6.11.4 Market Breakup by Public and Private Sector
        6.11.5 Market Forecast
    6.12 OPV (Oral Polio Vaccine) Vaccine Market
        6.12.1 Vaccine Overview
        6.12.2 Market Performance
        6.12.3 Market Breakup by Prescriber
        6.12.4 Market Breakup by Public and Private Sector
        6.12.5 Market Forecast
    6.13 MMR Vaccine Market
        6.13.1 Vaccine Overview
        6.13.2 Market Performance
        6.13.3 Market Breakup by Prescriber
        6.13.4 Market Breakup by Public and Private Sector
        6.13.5 Market Forecast
    6.14 Rotavirus Vaccine Market
        6.14.1 Vaccine Overview
        6.14.2 Market Performance
        6.14.3 Market Breakup by Prescriber
        6.14.4 Market Breakup by Public and Private Sector
        6.14.5 Market Forecast
    6.15 Hepatitis B Vaccine Market
        6.15.1 Vaccine Overview
        6.15.2 Market Performance
        6.15.3 Market Breakup by Prescriber
        6.15.4 Market Breakup by Public and Private Sector
        6.15.5 Market Forecast
    6.16 Pneumococcal Vaccine Market
        6.16.1 Vaccine Overview
        6.16.2 Market Performance
        6.16.3 Market Breakup by Prescriber
        6.16.4 Market Breakup by Public and Private Sector
        6.16.5 Market Forecast
    6.17 Meningococcal Vaccine Market
        6.17.1 Vaccine Overview
        6.17.2 Market Performance
        6.17.3 Market Breakup by Prescriber
        6.17.4 Market Breakup by Public and Private Sector
        6.17.5 Market Forecast
    6.18 Rabies Vaccine Market
        6.18.1 Vaccine Overview
        6.18.2 Market Performance
        6.18.3 Market Breakup by Prescriber
        6.18.4 Market Breakup by Public and Private Sector
        6.18.5 Market Forecast
    6.19 HPV Vaccine Market
        6.19.1 Vaccine Overview
        6.19.2 Market Performance
        6.19.3 Market Breakup by Prescriber
        6.19.4 Market Breakup by Public and Private Sector
        6.19.5 Market Forecast
    6.20 Hexavalent Vaccines
    6.21 Dengue Vaccines
7   SWOT Analysis
    7.1 Overview
    7.2 Strengths
    7.3 Weaknesses
    7.4 Opportunities
    7.5 Threats
8   Value Chain Analysis
    8.1 Exploratory Stage
    8.2 Preclinical and Clinical Development
    8.3 Regulatory Approval
    8.4 Manufacturing
    8.5 Marketing and Distribution
9   Porter’s Five Forces Analysis
    9.1 Overview
    9.2 Bargaining Power of Supplier
    9.3 Bargaining Power of Buyers
    9.4 Degree of Competition
    9.5 Threat of New Entrants
    9.6 Threat of Substitutes
10  Competitive Landscape
    10.1 Market Structure
    10.2 Market Breakup by Key Players
11  Pricing Analysis
12  Regulatory Framework
13  Key Players Profiles

    13.1 GlaxoSmithKline 
    13.2 Sanofi Aventis
    13.3 Serum Institute of India 
    13.4 Panacea Biotec
    13.5 Pfizer
    13.6 Novartis
    13.7 VHB Lifesciences
    13.8 Zydus Cadila
    13.9 MSD

List of Figures

Figure 1: India: Vaccine Market: Vaccine Development and Introduction
Figure 2: India: Vaccine Market: Major Drivers and Challenges
Figure 3: India: Vaccine Market: Doses Administered (in Million), 2018-2023
Figure 4: India: Vaccine Market: Sales Value (in INR Million), 2018-2023
Figure 5: India: Monovalent Vaccine Market: Value Breakup by Segment (in %), 2023
Figure 6: India: Combined Vaccine Market: Value Breakup by Segment (in %), 2023
Figure 7: India: Vaccine Market: Value Breakup by Age Group (in %), 2023
Figure 8: India: Vaccine Market Forecast: Doses Administered (in Million), 2024-2032
Figure 9: India: Vaccine Market Forecast: Sales Value (in INR Million), 2024-2032
Figure 10: India: BCG Vaccine Market: Doses Administered (in Million), 2018-2023
Figure 11: India: BCG Vaccine Market: Sales Value (in INR Million), 2018-2023
Figure 12: India: BCG Vaccine Market: Breakup by Prescriber (in %), 2023
Figure 13: India: BCG Vaccine Market: Breakup by Sector (in %), 2023
Figure 14: India: BCG Vaccine Market: Sales Value Forecast (in INR Million), 2024-2032
Figure 15: India: HIB Vaccine Market: Doses Administered (in Million), 2018-2023
Figure 16: India: HIB Vaccine Market: Sales Value (in INR Million), 2018-2023
Figure 17: India: HIB Vaccine Market: Breakup by Prescriber (in %), 2023
Figure 18: India: HIB Vaccine Market: Breakup by Sector (in %), 2023
Figure 19: India: HIB Vaccine Market: Sales Value Forecast (in INR Million), 2024-2032
Figure 20: India: Influenza Vaccine Market: Doses Administered (in Million), 2018-2023
Figure 21: India: Influenza Vaccine Market: Sales Value (in INR Million),
Figure 22: India: Influenza Vaccine Market: Breakup by Import and Domestic Manufacturing (in %), 2023
Figure 23: India: Influenza Vaccine Market: Breakup by Sector (in %), 2023
Figure 24: India: Influenza Vaccine Market: Sales Value Forecast (in INR Million), 2024-2032
Figure 25: India: Varicella Vaccine Market: Doses Administered (in Million), 2018-2023
Figure 26: India: Varicella Vaccine Market: Sales Value (in INR Million), 2018-2023
Figure 27: India: Varicella Vaccine Market: Breakup by Prescriber (in %), 2023
Figure 28: India: Varicella Vaccine Market: Breakup by Sector (in %), 2023
Figure 29: India: Varicella Vaccine Market: Sales Value Forecast (in INR Million), 2024-2032
Figure 30: India: Typhoid Vaccine Market: Doses Administered (in Million), 2018-2023
Figure 31: India: Typhoid Vaccine Market: Sales Value (in INR Million), 2018-2023
Figure 32: India: Typhoid Vaccine Market: Breakup by Prescriber (in %), 2023
Figure 33: India: Typhoid Vaccine Market: Breakup by Sector (in %), 2023
Figure 34: India: Typhoid Vaccine Market: Breakup by Type (in %), 2023
Figure 35: India: Typhoid Vaccine Market: Sales Value Forecast (in INR Million), 2024-2032
Figure 36: India: JE Vaccine Market: Doses Administered (in Million), 2018-2023
Figure 37: India: JE Vaccine Market: Sales Value (in INR Million), 2018-2023
Figure 38: India: JE Vaccine Market: Breakup by Prescriber (in %), 2023
Figure 39: India: JE Vaccine Market: Breakup by Sector (in %), 2023
Figure 40: India: JE Vaccine Market: Sales Value Forecast (in INR Million), 2024-2032
Figure 41: India: Measles Vaccine Market: Doses Administered (in Million), 2014 - 2016
Figure 42: India: Measles Vaccine Market: Sales Value (in INR Million), 2014 - 2016
Figure 43: India: Measles Vaccine Market: Breakup by Prescriber (in %), 2016
Figure 44: India: Measles Vaccine Market: Breakup by Sector (in %), 2016 
Figure 45: India: Tetanus Toxoid Vaccine Market: Doses Administered (in Million), 2018-2023
Figure 46: India: Tetanus Toxoid Vaccine Market: Sales Value (in INR Million), 2018-2023
Figure 47: India: Tetanus Toxoid Vaccine Market: Breakup by Prescriber (in %), 2023
Figure 48: India: Tetanus Toxoid Vaccine Market: Breakup by Sector (in %), 2023
Figure 49: India: Hepatitis A Vaccine Market: Doses Administered (in Million), 2018-2023
Figure 50: India: Hepatitis A Vaccine Market: Sales Value (in INR Million), 2018-2023
Figure 51: India: Hepatitis A Vaccine Market: Breakup by Prescriber (in %), 2023
Figure 52: India: Hepatitis A Vaccine Market: Breakup by Sector (in %), 2023
Figure 53: India: Hepatitis A Vaccine Market: Sales Value Forecast (in INR Million), 2024-2032
Figure 54: India: Rubella Vaccine Market: Doses Administered (in Million), 2014 - 2016
Figure 55: India: Rubella Vaccine Market: Sales Value (in INR Million), 2014 - 2016
Figure 56: India: Rubella Vaccine Market: Breakup by Prescriber (in %), 2016
Figure 57: India: Rubella Vaccine Market: Breakup by Sector (in %), 2016 
Figure 58: India: DPT Vaccine Market: Doses Administered (in Million), 2018-2023
Figure 59: India: DPT Vaccine Market: Sales Value (in INR Million), 2018-2023
Figure 60: India: DPT Vaccine Market: Breakup by Prescriber (in %), 2023
Figure 61: India: DPT Vaccine Market: Breakup by Sector (in %), 2023
Figure 62: India: DPT Vaccine Market: Sales Value Forecast (in INR Million), 2024-2032
Figure 63: India: OPV Vaccine Market: Doses Administered (in Million), 2018-2023
Figure 64: India: OPV Vaccine Market: Sales Value (in INR Million), 2018-2023
Figure 65: India: OPV Vaccine Market: Breakup by Prescriber (in %), 2023
Figure 66: India: OPV Vaccine Market: Breakup by Sector (in %), 2023
Figure 67: India: OPV Vaccine Market: Sales Value Forecast (in INR Million), 2024-2032
Figure 68: India: MMR Vaccine Market: Doses Administered (in Million), 2018-2023
Figure 69: India: MMR Vaccine Market: Sales Value (in INR Million), 2018-2023
Figure 70: India: MMR Vaccine Market: Breakup by Prescriber (in %), 2023
Figure 71: India: MMR Vaccine Market: Breakup by Sector (in %), 2023
Figure 72: India: MMR Vaccine Market: Sales Value Forecast (in INR Million), 2024-2032
Figure 73: India: Rotavirus Vaccine Market: Doses Administered (in Million), 2018-2023
Figure 74: India: Rotavirus Vaccine Market: Sales Value (in INR Million), 2018-2023
Figure 75: India: Rotavirus Vaccine Market: Breakup by Prescriber (in %), 2023
Figure 76: India: Rotavirus Vaccine Market: Breakup by Sector (in %), 2023
Figure 77: India: Rotavirus Vaccine Market: Sales Value Forecast (in INR Million), 2024-2032
Figure 78: India: Hepatitis B Vaccine Market: Doses Administered (in Million), 2018-2023
Figure 79: India: Hepatitis B Vaccine Market: Sales Value (in INR Million), 2018-2023
Figure 80: India: Hepatitis B Vaccine Market: Breakup by Prescriber (in %), 2023
Figure 81: India: Hepatitis B Vaccine Market: Breakup by Sector (in %), 2023
Figure 82: India: Hepatitis B Vaccine Market: Sales Value Forecast (in INR Million), 2024-2032
Figure 83: India: Pneumococcal Vaccine Market: Doses Administered (in Million), 2018-2023
Figure 84: India: Pneumococcal Vaccine Market: Sales Value (in INR Million), 2018-2023
Figure 85: India: Pneumococcal Vaccine Market: Breakup by Prescriber (in %), 2023
Figure 86: India: Pneumococcal Vaccine Market: Breakup by Sector (in %), 2023
Figure 87: India: Pneumococcal Vaccine Market: Sales Value Forecast (in INR Million), 2024-2032
Figure 88: India: Meningococcal Vaccine Market: Doses Administered (in '000), 2018-2024
Figure 89: India: Meningococcal Vaccine Market: Sales Value (in INR Million), 2018-2024
Figure 90: India: Meningococcal Vaccine Market: Breakup by Import and Domestic Manufacturing (in %), 2023
Figure 91: India: Meningococcal Vaccine Market: Breakup by Sector (in %), 2023
Figure 92: India: Meningococcal Vaccine Market: Sales Value Forecast (in INR Million), 2024-2032
Figure 93: India: Rabies Vaccine Market: Doses Administered (in Million), 2018-2023
Figure 94: India: Rabies Vaccine Market: Sales Value (in INR Million), 2018-2023
Figure 95: India: Rabies Vaccine Market: Breakup by Prescriber (in %), 2023
Figure 96: India: Rabies Vaccine Market: Breakup by Sector (in %), 2023
Figure 97: India: Rabies Vaccine Market: Sales Value Forecast (in INR Million), 2024-2032
Figure 98: India: HPV Vaccine Market: Doses Administered (in '000), 2018-2023
Figure 99: India: HPV Vaccine Market: Sales Value (in INR Million), 2018-2023
Figure 100: India: HPV Vaccine Market: Breakup by Prescriber (in %), 2023
Figure 101: India: HPV Vaccine Market: Breakup by Sector (in %), 2023
Figure 102: India: HPV Vaccine Market: Sales Value Forecast (in INR Million), 2024-2032
Figure 103: India: Hexavalent Vaccine Market: Doses Administered (in Million), 2018-2024
Figure 104: India: Hexavalent Vaccine Market: Sales Value (in INR Million), 2018-2024
Figure 105: India: Hexavalent Vaccine Market: Breakup by Import and Domestic Manufacturing (in %), 2023
Figure 106: India: Hexavalent Vaccine Market: Breakup by Sector (in %), 2023
Figure 107: India: Hexavalent Vaccine Market Forecast: Sales Value (in INR Million), 2024-2032
Figure 108: India: Dengue Vaccine Market: Sales Value Forecast (in INR Million), 2024-2032
Figure 109: India: Vaccine Market: SWOT Analysis
Figure 110: India: Vaccine Market: Value Chain Analysis
Figure 111: India: Vaccine Market: Price Analysis
Figure 112: India: Vaccines Market: Standard Procedure of Introducing New Vaccine

List of Tables

Table 1: India: Vaccine Market: Key Industry Highlights, 2023 and 2032
Table 2: India: BCG Vaccine: Overview
Table 3: India: HIB Vaccine: Overview
Table 4: India: Influenza Vaccine: Overview
Table 5: India: Varicella Vaccine: Overview
Table 6: India: Typhoid Vaccine: Overview
Table 7: India: JE Vaccine: Overview
Table 8: India: Measles Vaccine: Overview
Table 9: India: Tetanus Toxoid Vaccine: Overview
Table 10: India: Hepatitis A Vaccine: Overview
Table 11: India: Rubella Vaccine: Overview
Table 12: India: DPT Vaccine: Overview
Table 13: India: OPV Vaccine: Overview
Table 14: India: MMR Vaccine: Overview
Table 15: India: Rotavirus Vaccine: Overview
Table 16: India: Hepatitis B Vaccine: Overview
Table 17: India: Pneumococcal Vaccine: Overview
Table 18: India: Meningococcal Vaccine: Overview
Table 19: India: Rabies Vaccine: Overview
Table 20: India: HPV Vaccine: Overview
Table 21: India: Hexavalent Vaccine: Overview
Table 22: India: Vaccine Market: Key Components in Drug Delivery

Indian Vaccine Market Report by Monovalent and Combined Vaccines (BCG, HIB, Influenza, Varicella, Typhoid, Japanese Encephalitis, Measles, Tetanus Toxoid, Hepatitis A, Rubella, Diphtheria, Tetanus, and Pertussis (DPT), Oral Polio Vaccine (OPV), MMR, Rotavirus, Hepatitis B, Pneumococcal, Meningococcal, Rabies, HPV, Hexavalent, Dengue Vaccines) 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More